Abstract
The cystic fibrosis transmembrane conductance regulator (CFTR) gene of 110 cystic fibrosis (CF) patients from the south-west of Germany was screened for 12 different mutations. This analysis resulted in an identification of 79% of all CF mutations and a complete genotype in 66% of the families. The most common mutation found was ΔF508 (67%). Another 5 mutations accounted for a further 12.5% (4% G542X; 3% R553X; 3% N1303K; 2% 1717-1 G→A; 0.5% G551D) whereas 6 mutations (R117H, A455E, ΔI507, S549I, S549N, and R1162X) were not found. Fifty-four (49%) patients were AF508 homozygotes and 18 (16.5%) were compound heterozygotes for ΔF508 and one of the rarer mutations. These frequencies differ slightly from those found in the north of Germany and considerably from those reported from the south of Europe, which seems to be consistent with a north to south decline of the relative abundance of ΔF508. Two patients, age 6 and 25 years, were compound heterozygotes for G542X and N1303K. The clinical features of the 6 year old were characterised by severe gastrointestinal and as yet only mild pulmonary complications whereas the 25 year old manifested severe pulmonary and gastrointestinal symptoms indicating that the N1303K mutation of the C-terminal CFTR nucleotide binding fold significantly impairs protein function in both the pancreas and the lungs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson MP, Gregory RJ, Thompson S, Souza DW, Sucharita P, Mulligan RC, Smith AE, Welsh MJ (1991a) Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253:202–205
Anderson MP, Berger HA, Rich DR, Gregory RJ, Smith AE, Welsh MJ (1991b) Nucleotide triphosphates are required to open the CFTR chloride channel. Cell 67:775–784
Cutting GR, Kasch LM, Rosenstein BJ, Zielinski J, Tsui L-C, Antonarakis SE, Kazazian HH Jr (1990) A cluster of cystic fibrosis mutations in the first nucleotide binding fold of the cystic fibrosis conductance regulator protein. Nature 346:366–369
Davies K (1990) Complementary endeavors. Nature 348:110
Dean M, White MB, Amos J, Gerrard B, Stewart C, Khaw K-T, Leppert M (1990) Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell 61:863–870
Devoto M, Ronchetto P, Fanen P, Orriols JJT, Romeo G, Goossens M, Ferrari M, Magnani C, Seia M, Cremonesi L (1991) Screening for non-deltaF508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. Am J Hum Genet 48:1127–1132
European Working Group on CF Genetics (EWGCFG) (1990) Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. Hum Genet 85:436–445
Gasparini P, Nunes V, Savoia A, Dognini M, Morral N, Gaona A, Bonnizzato A, Chillon M, Sangiuolo F, Novelli G, Dallapiccola B, Pignatti PF, Estivill X (1991) The search for south European cystic fibrosis mutations: identification of two new mutations four variants, and intronic sequences. Genomics 10:193–200
Guillermit H, Fanen P, Ferec C (1990) A 3′ splice site consensus sequence mutation in the cystic fibrosis gene. Hum Genet 85:450–453
Kartner N, Hanrahan JW, Jensen TJ, Naismith AL, Sun S, Ackerley CA, Reyes EF, Tsui L-C, Rommens JM, Bear CE, Riordan JR (1991) Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell 64:681–691
Kerem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui L-C (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080
Kerem B-S, Zielinski J, Markiewicz D, Bozon D, Gazit E, Yhav J, Kennedy D, Riordan JR, Collins FS, Rommens JM, Tsui L-C (1990) Identification of mutations in regions corresponding to the two nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci USA 87:8447–8451
Osborne L, Knight R, Santis G, Hodson M (1991) A mutation in the second nucleotide binding fold of the cystic fibrosis gene. Am J Hum Genet 48:608–612
Plieth J, Rininsland F, Schlösser M, Cooper DN, Reiss J (1992) Single strand conformation polymorphism (SSCP) analysis of exon 11 of the CFTR gene reliably detects more than one third of non-ΔF508 mutations in German cystic fibrosis patients. Hum Genet 88:283–287
Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, Zielinski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1072
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Scheffer H, Verlind E, Penninga D, Te Meerman G, Kate L ten, Luys C (1989) Rapid screening for ΔF508 deletion in cystic fibrosis. Lancet II:1345–1346
Trezise AEO, Buchwald M (1991) In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 353:434–437
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindner, M., Wolf, A., Moh, B. et al. The spectrum of CFTR mutations in south-west German cystic fibrosis patients. Hum Genet 90, 267–269 (1992). https://doi.org/10.1007/BF00220076
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00220076